Arcutis Biotherapeutics
ARQT
ARQT
185 hedge funds and large institutions have $1.18B invested in Arcutis Biotherapeutics in 2024 Q2 according to their latest regulatory filings, with 47 funds opening new positions, 59 increasing their positions, 55 reducing their positions, and 29 closing their positions.
Holders
185
Holders Change
+18
Holders Change %
+10.78%
% of All Funds
2.69%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.06%
New
47
Increased
59
Reduced
55
Closed
29
Calls
$7.03M
Puts
$2.73M
Net Calls
+$4.3M
Net Calls Change
+$8.98M
Top Buyers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
DM
201
Deerfield Management
New York
| – | -$334K | -33,714 | Closed |
|
202
Simplex Trading
Chicago,
Illinois
| – | -$255K | -25,795 | Closed |
|
203
Vontobel Holding
Zurich,
Switzerland
| – | -$208K | -21,000 | Closed |
|
|
CSS
204
Cubist Systematic Strategies
Stamford,
Connecticut
| – | -$205K | -20,705 | Closed |
|
205
Koshinski Asset Management
Decatur,
Illinois
| – | -$198K | -20,000 | Closed |
|
|
QL
206
Quarry LP
New York
| – | -$168K | -17,000 | Closed |
|
|
QT
207
Quantbot Technologies
New York
| – | -$121K | -12,200 | Closed |
|
|
NRD
208
Nebula Research & Development
New York
| – | -$110K | -11,100 | Closed |
|
|
RJFSA
209
Raymond James Financial Services Advisors
St. Petersburg,
Florida
| – | -$106K | -10,675 | Closed |
|
|
CFM
210
Catalyst Funds Management
Sydney NSW,
Australia
| – | -$85.2K | -8,600 | Closed |
|
|
A
211
AlphaQuest
New York
| – | -$63.9K | -6,452 | Closed |
|
|
MLICM
212
Metropolitan Life Insurance Company (MetLife)
New York
| – | -$43.9K | -4,431 | Closed |
|
|
AWM
213
Avior Wealth Management
Omaha,
Nebraska
| – | -$218 | -22 | Closed |
|